Recce Pharma picks up Chinese patent for anti-infective drugs Posted on May 7, 2024September 25, 2024 by recce_com Recce Pharma picks up Chinese patent for anti-infective drugs
Recce weighs in on Q1 2024 as cash increases 100% Posted on April 22, 2024September 25, 2024 by recce_com Recce weighs in on Q1 2024 as cash increases 100%
Recce Pharmaceuticals up 6% on new antibiotic production milestone Posted on April 16, 2024September 25, 2024 by recce_com Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals selected to participate in UK Government Innovation Agency’s AMR Mission 2024 Posted on April 11, 2024September 25, 2024 by recce_com Recce Pharmaceuticals selected to participate in UK Government Innovation Agency’s AMR Mission 2024
Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel Posted on April 9, 2024September 25, 2024 by recce_com Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel
Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel Posted on April 8, 2024September 25, 2024 by recce_com Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel
Recce Pharmaceuticals inks new patent for flagship drug in Israel Posted on April 3, 2024September 25, 2024 by recce_com Recce Pharmaceuticals inks new patent for flagship drug in Israel
Recce reaches testing milestone for UTI, Uroseptis antibiotic Posted on March 22, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Uroseptis antibiotic
Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis Posted on March 18, 2024September 25, 2024 by recce_com Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis
Recce reaches testing milestone for UTI, Urosepsis antibiotic Posted on March 17, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Urosepsis antibiotic
